Published: Jan 07, 2022 By Gail Dutton Cartesian Therapeutics is developing non-permanent cell therapies that can be used soon…
Super UserJanuary 18, 2022
It takes more than a great idea to accomplish a great project. Our research and experience have convinced us that…
Super UserJanuary 18, 2022
Cartesian Therapeutics is developing non-permanent cell therapies that can be used soon after diagnosis and address a wide range of…
Super UserJanuary 18, 2022
-- Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine granted approval in South Korea GAITHERSBURG, Md., Jan.…
Super UserJanuary 18, 2022
January 10, 2022 by Ronald Piervincenzi The COVID-19 pandemic made the last year both an extraordinary and challenging time to…
Super UserJanuary 12, 2022
Under pressure of the COVID-19 pandemic, multitudes of clinical trials of new medications and treatments have moved to a decentralized…
Super UserJanuary 12, 2022
ROCKVILLE, Md., Jan. 10, 2022 /PRNewswire/ -- ASCENTTM, a Phase III clinical trial conducted in partnership with AbbVie, is expected…
Super UserJanuary 10, 2022
Leiden, May 27, 2021 - MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just opened their Phenotypic Screening Center.…
Super UserJanuary 10, 2022